GRANTS FOR INNOVATION

BioVentures Institute Ltd. received funding from the European Union (EU) via National Centre for Research and Development (NCBiR) in the amount of 3 209 930 PLN (Priority axis 1: Research and development of modern technologies, Action 1.4: Support for goal-oriented projects; agreement no.: POIG.01.04.00-22-140/12) for the development of novel, recombinant DNA based technology in cooperation with the Molecular Biotechnology Department, Chemistry Division and Molecular Biology Department, Biology Division, University of Gdansk, of generating artificial hyper immunogenic antigens/vaccines, entitled: „The new technology of producing preventive and therapeutic vaccines for multiple stimulation of the human immune system”. The technology is universal, thus can be applied to most antigens, however, our first targets are HIV, HCV and HBV viruses. The project is carried out between 1 June 2013 and 30 June 2015.

For more information about this project, please contact:

Professor dr hab. Piotr Skowron, phone: 0048 660 15 34 24

 

More information about EU grants can be found at:

http://europa.eu/index_pl.htm
http://www.poig.gov.pl/
http://www.mrr.gov.pl/
http://www.mswia.gov.pl/
http://www.parp.gov.pl/index/main/

 

A PROJECT CO-FINANCED BY THE EUROPEAN UNION FROM
THE EUROPEAN REGIONAL DEVELOPMENT FUND

 

Partners

 

A PROJECT CO-FINANCED BY THE EUROPEAN UNION FROM THE EUROPEAN REGIONAL DEVELOPMENT FUND GRANTS FOR INNOVATION